Catalog No.
Product Name
Application
Product Information
Citations
-
Purine Nucleoside Analog
6-Methylpurine-β-D-(3-azido-3-deoxy)riboside is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms include the inhibition of DNA synthesis and the induction of apoptosis. Additionally, this compound serves as a versatile click chemistry reagent, featuring an azide group capable of participating in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN functionalized compounds. -
Purine Nucleoside Analog
1-(5-O-Methoxytrityl-2-deoxy-β-D-xylofuranosyl)uracil is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells, making it a valuable tool for cancer research. This compound can be used in studies focused on elucidating mechanisms of tumorigenesis and therapeutic resistance in various malignancies. -
Purine Nucleoside Analog
2′-O-Hexadecyl-adenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a vital tool in cancer research. This compound is suitable for studies focusing on nucleoside metabolism and therapeutic interventions in hematological cancers. -
Purine Nucleoside Analog
2'-Deoxy-8-(phenylmethoxy)guanosine is a purine nucleoside analog that exhibits notable antitumor activity, particularly against indolent lymphoid malignancies. Its biological mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable reagent for cancer research. This compound is significant for studies aimed at exploring therapeutic strategies in oncology and understanding the underlying pharmacological effects of nucleoside analogs. -
Purine Nucleoside Analog
Isocytidine is a purine nucleoside analog that targets nucleic acid synthesis. This compound exhibits notable antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic applications. -
Purine Nucleoside Analog
8-Bromo-9-(β-D-xylofuranosyl) guanine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are primarily attributed to the inhibition of DNA synthesis and the induction of apoptosis. This compound is a valuable tool for research applications focused on cancer therapeutics and the mechanistic study of nucleoside analogs in oncology. -
Purine Nucleoside Analog
5'-DMTr-2,2'-anhydrothymidine is a purine nucleoside analog that exhibits significant antitumor activity. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it particularly relevant for research into indolent lymphoid malignancies. This compound serves as a valuable tool in cancer research, aiding in the exploration of therapeutic strategies targeting nucleoside metabolism and cellular proliferation. -
Purine Nucleoside Analog
3′-Azido-3′-deoxy-5′-O-(triphenylmethyl)thymidine is a purine nucleoside analog that demonstrates significant antitumor activity primarily against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is useful in research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
N4-Benzyloxy-5’-O-(4,4’-dimethoxytrityl)-aracytidine is a purine nucleoside analog primarily designed to interfere with DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inducing apoptosis and disrupting cellular replication processes. It serves as a valuable tool in cancer research, facilitating investigations into therapeutic strategies targeting nucleoside metabolism and tumor cell proliferation. -
Purine Nucleoside Analog
1-O-Acetyl-2,3,5-tri-O-benzoyl-5(R)-C-methyl-D-ribo furanose is a purine nucleoside analog that primarily targets nucleoside metabolism pathways. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms that involve the inhibition of DNA synthesis and induction of apoptosis. This compound is valuable for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
6-Methylpurine-2’-deoxy-2’-fluoro-beta-D-arabinoriboside is a purine nucleoside analog that exerts its effects primarily through the inhibition of DNA synthesis. This compound demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies, and induces apoptosis in cancer cells. Its properties make it a valuable tool for research into cancer mechanisms and therapeutic interventions. -
Purine Nucleoside Analog
3’-O-(4,4’-Dimethoxy trityl)-2’-O-(2-methoxyethyl)-5-methyluridine is a purine nucleoside analog that exhibits significant antitumor activity. It primarily targets indolent lymphoid malignancies, functioning through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on the development of new anticancer therapies. -
Purine Nucleoside Analog
3’-O-(t-Butyldiphenylsilyl) thymidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for cancer research. This analog is instrumental in studying the pathways related to tumorigenesis and cell death, contributing to the development of novel therapeutic strategies. -
Purine Nucleoside Analog
(1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for investigating therapeutic strategies aimed at targeting specific types of lymphoid cancers. -
Purine Nucleoside Analog
5-Iodo-3’-deoxy-3’-fluorouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suitable for studies focusing on nucleoside metabolism and therapeutic strategies in oncology. -
Purine Nucleoside Analog
2-Deoxyuridine is a purine nucleoside analog that primarily targets DNA synthesis mechanisms. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting DNA replication and promoting apoptosis in cancer cells. Its applications include the study of cancer biology and the development of novel therapeutic strategies. -
Purine Nucleoside Analog
1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for cancer research. This reagent is suitable for studies focused on understanding the effects of nucleoside analogs in tumor cell biology. -
Purine Nucleoside Analog
2′,3′,5′-Tri-O-acetyl-6-chloroguanosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is useful for investigations into the molecular pathways of tumorigenesis and therapeutic resistance. -
Purine Nucleoside Analog
4’,5’-Didehydro-5’-deoxy thymidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is useful for exploring therapeutic strategies and mechanisms involved in the treatment of various malignancies. -
Purine Nucleoside Analog
2’-beta-C-Methyl-4-thiouridine is a purine nucleoside analog exhibiting significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound can be used to explore therapeutic strategies and evaluate the cellular responses within various malignancies. -
Nucleoside Analog
3'-NH2-ddT (3′-Amino-2′,3′-dideoxythymidine) serves as a nucleoside analog for the synthesis of nucleic acids. This compound is utilized to introduce amino functionalities into oligonucleotides, allowing for enhanced binding properties and biological stability. It plays a crucial role in various areas of genetic research, including the development of therapeutic oligonucleotides and the study of nucleic acid interactions. -
Purine Nucleoside Analog
2’,3’,5’-Tri-O-benzoyl-5-iodouridine is a purine nucleoside analog known for its potent antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool for researchers studying cancer biology and therapeutic strategies targeting nucleoside metabolism. -
Purine Nucleoside Analog
2'-Amino-2'-deoxy-β-D-arabino-5-methyl uridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for studies focusing on cellular proliferation, cancer therapies, and the underlying mechanisms of tumor development. -
Adenosine Analog
8-Allyloxyadenosine is an adenosine analog primarily targeting adenosine receptors. This compound exhibits significant biological activity as a smooth muscle vasodilator and has demonstrated potential in inhibiting cancer progression. It serves as a valuable tool in research applications focused on cardiovascular health and cancer therapy. -
Purine Nucleoside Analog
7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro guanosine is a purine nucleoside analog that exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include inhibition of DNA synthesis and induction of apoptosis. Additionally, this compound serves as a click chemistry reagent, incorporating an alkyne group that allows for copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. This versatile profile makes it valuable for various biochemical research applications. -
Adenosine Analog
2-(4-Cyanobenzyl)thioadenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits potent vasodilatory effects on smooth muscle, making it of interest in cardiovascular research. Additionally, it has demonstrated potential in inhibiting cancer progression, making it a valuable tool for cancer biology studies. -
Purine Nucleoside Analog
4’-C-Methyl-2-thiouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable for research applications aimed at understanding the biochemical pathways involved in cancer progression and therapeutic resistance. -
Nucleoside Analogue
Methyl 3,5-di-O-(2,4-dichlorobenzyl)-D-ribofuranoside is a ribofuranose nucleoside analogue that acts as a structural mimic of naturally occurring nucleosides. It exhibits potential biological activity by interfering with nucleic acid synthesis and cellular processes. This compound is primarily utilized in research related to antiviral drug development and studies on nucleoside transport mechanisms. -
Purine Nucleoside Analog
5’-Deoxy-5’-furfurylamino thymidine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. This compound primarily functions by inhibiting DNA synthesis, leading to the induction of apoptosis in cancer cells. It serves as a valuable tool for research focused on cancer treatment and the mechanisms of action of nucleoside analogs in therapeutic applications. -
Purine Nucleoside Analog
5-(2-Amino-2-oxoethyl)uridine is a purine nucleoside analog that exerts significant antitumor activity, particularly against indolent lymphoid malignancies. Its biological mechanisms include inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is applicable in studies aimed at understanding cellular responses to nucleoside analogs and their effects on tumor progression. -
Purine Nucleoside Analog
3’-F-3’-dG(iBu)-2’-phosphoramidite is a purine nucleoside analog primarily targeting DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are attributed to mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis, making it valuable for research in cancer biology and therapeutic applications. -
Purine Nucleoside Analog
3’-Deoxy-5-fluorouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves inhibiting DNA synthesis, which subsequently leads to the induction of apoptosis in cancer cells. This compound is utilized in various research applications focused on cancer therapeutics and the study of nucleoside metabolism. -
Purine Nucleoside Analog
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(naphthalen-1-yl)purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms are primarily attributed to the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool in cancer research, enabling the exploration of therapeutic strategies targeting nucleoside metabolism and cellular proliferation. -
Purine Nucleoside Analog
1-(3’-O-[4,4’-Dimethoxytrityl]-alpha-L-threofuranosyl)-thymine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research focused on cancer biology and the development of novel therapeutic strategies targeting lymphoid malignancies. -
Purine Nucleoside Analog
5’-Deoxy-5’-N-methylaminothymidine is a purine nucleoside analog that exhibits significant antitumor activity. It targets indolent lymphoid malignancies primarily through the inhibition of DNA synthesis and the induction of apoptosis. This compound is highly valuable for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
2’,3’,5’-Tri-O-acetyl-6-S-methyl-6-thio-guanosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are primarily mediated through the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool for research into cancer therapeutics and the mechanistic understanding of purine metabolism in malignant cells. -
Purine Nucleoside Analog
4-Amino-5-cyano-1-(β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a purine nucleoside analog that exhibits significant antitumor activity. It primarily targets indolent lymphoid malignancies through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool in cancer research, particularly in studying therapeutic strategies against specific malignancies. -
Purine Nucleoside Analog
2’-Deoxy-2’-fluoro-5-methyl-4’-thio-a-D-arabino uridine is a purine nucleoside analog designed to interfere with nucleic acid metabolism. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting DNA synthesis and inducing apoptosis. This compound is valuable for cancer research, particularly in studying the mechanisms of tumor cell proliferation and potential therapeutic strategies. -
Purine Nucleoside Analog
3'-Deoxy-3'-fluoro-3-deazauridine is a purine nucleoside analog that primarily targets DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting nucleic acid synthesis and inducing apoptosis. Its applications in cancer research make it a valuable tool for investigating therapeutic strategies against various malignancies. -
Purine Nucleoside Analog
2’-O-Methyl-5-hydroxymethyluridine is a purine nucleoside analog primarily involved in inhibiting DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as the induction of apoptosis. Its potential applications in cancer research make it a valuable tool for studying tumor biology and therapeutic strategies. -
Purine Nucleoside Analog
3’-Deoxy-3’-α-C-methyl-N6,N6-dimethyladenosine is a purine nucleoside analog that exerts significant antitumor activity by targeting indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This reagent is essential for studies on nucleoside metabolism and therapeutic strategies in oncology. -
Purine Nucleoside Analog
2',3'-Isopropylidene-5-hydroxyuridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is useful in studies aimed at understanding nucleoside metabolism and therapeutic interventions in oncology. -
Purine Nucleoside Analog
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(5-phenylpyridin-3-yl)purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are primarily attributed to the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound can be utilized in investigations aimed at understanding nucleotide metabolism and developing novel therapeutic strategies for malignancies. -
Purine Nucleoside Analog
3′-Deoxy-3′-fluorocytidine is a purine nucleoside analog known for its antitumor activities. This compound effectively inhibits DNA synthesis and induces apoptosis, making it a valuable tool in the study of indolent lymphoid malignancies. Its ability to mimic natural nucleosides allows for versatile applications in cancer research and therapeutic development. -
Purine Nucleoside Analog
(1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol is a purine nucleoside analog known for its broad antitumor activity against indolent lymphoid malignancies. This compound exerts its anticancer effects primarily through the inhibition of DNA synthesis and the induction of apoptosis. It serves as a valuable tool in cancer research, particularly in studies focused on lymphoid cancer therapies and the modulation of cellular proliferation pathways. -
Purine Nucleoside Analog
N4-Benzoyl-5-methylcytidine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are primarily attributed to the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable in research applications focused on exploring novel therapies for cancer treatment and understanding the mechanisms of nucleoside analogs in oncological contexts. -
Purine Nucleoside Analog
2-Bromo-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine is a purine nucleoside analog that exhibits significant antitumor activity. This compound primarily targets indolent lymphoid malignancies through mechanisms including the inhibition of DNA synthesis and the induction of apoptosis. It is a valuable tool for researchers investigating therapies for cancer and related cellular processes. -
Purine Nucleoside Analog
2-Amino-3,7-dihydro-5-iodo-7-β-D-ribofuranosyl-4H-pyrrolo[2,3-d]pyrimidin-4-one is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is utilized in various studies aimed at understanding the molecular dynamics of tumorigenesis and therapeutic interventions. -
Purine Nucleoside Analog
3’-Deoxy-5-trifluoromethyluridine is a purine nucleoside analog that exhibits notable antitumor activity, specifically against indolent lymphoid malignancies. Its mechanisms of action involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for studies focusing on the development of therapeutic strategies targeting nucleoside pathways in oncology. -
Adenosine Analog
N6,N6-Dimethyl-3'-beta-C-methyl-adenosine is an adenosine analog that primarily functions as a smooth muscle vasodilator. This compound has demonstrated potential to inhibit cancer progression, making it valuable for various research applications in oncology and cardiovascular studies. Its unique structural features enable the exploration of adenosine signaling pathways and therapeutic interventions targeting vascular and tumor growth regulation.
